Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial.

Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1373-1380. doi: 10.2215/CJN.13921217. Epub 2018 Aug 21.

PMID:
30131425
2.

Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.

Beveridge LA, Khan F, Struthers AD, Armitage J, Barchetta I, Bressendorff I, Cavallo MG, Clarke R, Dalan R, Dreyer G, Gepner AD, Forouhi NG, Harris RA, Hitman GA, Larsen T, Khadgawat R, Marckmann P, Mose FH, Pilz S, Scholze A, Shargorodsky M, Sokol SI, Stricker H, Zoccali C, Witham MD.

J Am Heart Assoc. 2018 May 30;7(11). pii: e008273. doi: 10.1161/JAHA.117.008273. Review.

3.

Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.

Bressendorff I, Hansen D, Schou M, Silver B, Pasch A, Bouchelouche P, Pedersen L, Rasmussen LM, Brandi L.

Kidney Int Rep. 2016 Dec 30;2(3):380-389. doi: 10.1016/j.ekir.2016.12.008. eCollection 2017 May.

4.

The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.

Bressendorff I, Hansen D, Schou M, Kragelund C, Brandi L.

BMJ Open. 2017 Jun 23;7(6):e016795. doi: 10.1136/bmjopen-2017-016795.

5.

The Effect of High Dose Cholecalciferol on Arterial Stiffness and Peripheral and Central Blood Pressure in Healthy Humans: A Randomized Controlled Trial.

Bressendorff I, Brandi L, Schou M, Nygaard B, Frandsen NE, Rasmussen K, Ødum L, Østergaard OV, Hansen D.

PLoS One. 2016 Aug 10;11(8):e0160905. doi: 10.1371/journal.pone.0160905. eCollection 2016.

6.

Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex.

Røder G, Geironson L, Bressendorff I, Paulsson K.

J Virol. 2008 Sep;82(17):8246-52. doi: 10.1128/JVI.00207-08. Epub 2008 Apr 30. Review. No abstract available.

Supplemental Content

Loading ...
Support Center